Skip to main content
Glama

三域医研 · 科研算法引擎 (SanYu Research Engine)

Toxicology assessment / 毒理评估

toxicology_assess
Read-only

Toxicology assessment / 毒理评估 | USE WHEN: nonclinical toxicology risk: hERG / DILI / genotoxicity, overall risk level | ALIASES: 毒理评估, 毒性风险, 遗传毒, toxicology, nonclinical safety, 安全评价 | RETURNS: 毒性风险分级

Tool call template

Replace each placeholder with a value matching the input schema. Only required parameters are included; add optional parameters as needed.

{
  "id": 1,
  "jsonrpc": "2.0",
  "method": "tools/call",
  "params": {
    "arguments": {
      "hERG_IC50_nM": "<hERG_IC50_nM>"
    },
    "name": "toxicology_assess"
  }
}

Input Schema

NameRequiredDescriptionDefault
logPNologP
hERG_IC50_nMYeshERG IC50 (nM),心脏毒性核心输入,必填
daily_dose_mgNo日剂量 (mg)
expected_Cmax_nMNo预期 Cmax (nM)

Schema Changelog

Changes observed during successful MCP inspections.

  1. Changed2 schema fields changed
    • changedInput schema / properties / hERG_IC50_nM / description
      Previous value: -"hERG IC50 (nM)"New value: +"hERG IC50 (nM),心脏毒性核心输入,必填"
    • changedInput schema / required
      Previous value: -[]New value: +[
      +  "hERG_IC50_nM"
      +]
  2. Added

TDQS

A3.6/5.0
Behavior3/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, destructiveHint=false, and openWorldHint=false, so the safety profile is covered by structured data. The description adds the return payload in concept ('RETURNS: 毒性风险分级') and the assessed domains, but says nothing about the scoring model, assumptions, or what inputs drive the grading. Credit is modest because the annotation block carries the operational burden.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Pipe-delimited sections front-load the 'USE WHEN' trigger ahead of aliases, so the most useful content appears first. The ALIASES block partially duplicates the bilingual title, which is minor template overhead rather than real waste.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness3/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a 4-parameter, single-required-input assessment tool with no output schema, the definition states what comes back only as a label ('toxicity risk grading') without any structure or interpretation guidance. The required-input expectation lives entirely in the schema. Adequate to select and call, but thin on what the agent should expect to do with the result.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, and the schema itself flags hERG_IC50_nM as required and the cardiac-toxicity core input. The description adds no parameter-level meaning beyond that, so baseline 3 applies; there is no guidance on how logP, daily_dose_mg, or expected_Cmax_nM interact with the risk grade.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names the resource (nonclinical toxicology assessment) and the specific risk domains it covers: hERG, DILI, genotoxicity, and an overall risk level. That is enough for an agent to tell it apart from pk_pd_assess or animal_dose_volume. The verb is implicit rather than a crisp action verb, which keeps it short of a 5.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The explicit 'USE WHEN: nonclinical toxicology risk' clause gives a clear triggering context with concrete sub-cases (hERG / DILI / genotoxicity). It does not name when NOT to use it or point to a sibling alternative, so routing among the PK/tox family is left to inference.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.